MARC details
000 -LEADER |
fixed length control field |
04280naaaa2201261uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/77108 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714184538.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-0365-2572-3 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036525730 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036525723 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-0365-2572-3 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
M |
Source |
bicssc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Subramanian, Subree |
Relator code |
edt |
9 (RLIN) |
1605808 |
245 10 - TITLE STATEMENT |
Title |
Cancer Immunology |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Basel, Switzerland |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2021 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (316 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
Source of heading or term |
bicssc |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
NKG2D |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CAR T |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
IL-7 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
prostate cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD19-CAR-T |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
B cell aplasia |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
KIR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PD-1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
inhibitory CAR |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor-infiltrating lymphocytes |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor microenvironment |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
NK cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer stem cells (CSCs) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antibody-dependent cellular cytotoxicity (ADCC) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
differentiation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cytotoxicity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
IFN-γ |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
osteoclasts |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
MICA/B mAb |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
DNA methylation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
RNA methylation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
S-adenosylmethionine (SAM) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
innate immunity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
adaptive immunity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
T cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
m6A |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
PD-L1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
resistance |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune checkpoints |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer vaccine |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
combination immunotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
TCR diversity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
organ transplantation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
carcinoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
epidemiologic studies |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunosuppression |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CTLA-4 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Treg cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune checkpoint inhibitors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD28 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antigen-presenting cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
IL15 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
colon cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
melanoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
uveal |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BAP1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
anti-PD-1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
anti-CTLA-4 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
TIL |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
classical and endemic Kaposi Sarcoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
systemic treatment |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
multi-state modelling |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
treatment free interval |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chemotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
interferon |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
triple negative breast cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunomodulation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bispecific antibody |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
sortase A |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chemo-enzymatic approach |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
anti-CD20 antibody |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Fab |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BiFab |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
colorectal cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dendritic cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Atypical Chemokine Receptor 4 (ACKR4) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
T-cell priming |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune checkpoint blockade |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
primary liver cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
kynurenine pathway |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune evasion |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
indoleamine 2,3 dioxygenase 1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tryptophan 2,3 dioxygenase 2 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
IDO inhibitor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antigen presenting cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Zhao, Xianda |
Relator code |
edt |
9 (RLIN) |
1605809 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Subramanian, Subree |
Relator code |
oth |
9 (RLIN) |
1605808 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Zhao, Xianda |
Relator code |
oth |
9 (RLIN) |
1605809 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/4727">https://mdpi.com/books/pdfview/book/4727</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/77108">https://directory.doabooks.org/handle/20.500.12854/77108</a> |
-- |
0 |
Public note |
DOAB: description of the publication |